Literature DB >> 29635003

STAT3: The art of multi-tasking of metabolic and immune functions in obesity.

Wei Hu1, Jianjun Lv2, Mengzhen Han3, Zhi Yang2, Tian Li2, Shuai Jiang4, Yang Yang5.   

Abstract

Signal transducer and activator of transcription 3 (STAT3) is a transcription factor that has recently attracted increased attention. Accumulating studies have demonstrated that STAT3 plays an important role in various diseases, such as cancer and ischemic injury. In light of the distinctive effects of STAT3 on the regulation of metabolism and immune responses, we present the elaborate network of STAT3 in obesity. In this review, we first introduce the general background of STAT3, including a discussion regarding the STAT family and the characterization and regulation of STAT3. Then, we describe the STAT3 signaling network and its pathophysiological roles in lipid and glucose metabolism and immune function. Finally, we highlight the research progress regarding STAT3 in obesity. The information presented here may be useful for the design of future studies and may highlight the potential of STAT3 as a future therapeutic target for obesity.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Immune; Lipid; Metabolism; Obesity; Signal transducer and activator of transcription 3

Mesh:

Substances:

Year:  2018        PMID: 29635003     DOI: 10.1016/j.plipres.2018.04.002

Source DB:  PubMed          Journal:  Prog Lipid Res        ISSN: 0163-7827            Impact factor:   16.195


  10 in total

1.  Interleukin-6 derived from cutaneous deficiency of stearoyl-CoA desaturase- 1 may mediate metabolic organ crosstalk among skin, adipose tissue and liver.

Authors:  Sabrina N Dumas; Chang-An Guo; Jason K Kim; Randall H Friedline; James M Ntambi
Journal:  Biochem Biophys Res Commun       Date:  2018-11-22       Impact factor: 3.575

2.  Arctiin-reinforced antioxidant microcarrier antagonizes osteoarthritis progression.

Authors:  Yang Liu; Mingzhuang Hou; Zejun Pan; Xin Tian; Zhijian Zhao; Tao Liu; Huilin Yang; Qin Shi; Xi Chen; Yijian Zhang; Fan He; Xuesong Zhu
Journal:  J Nanobiotechnology       Date:  2022-06-27       Impact factor: 9.429

3.  Improvement of Glycaemia and Endothelial Function by a New Low-Dose Curcuminoid in an Animal Model of Type 2 Diabetes.

Authors:  Sara Oliveira; Tamaeh Monteiro-Alfredo; Rita Henriques; Carlos Fontes Ribeiro; Raquel Seiça; Teresa Cruz; Célia Cabral; Rosa Fernandes; Fátima Piedade; Maria Paula Robalo; Paulo Matafome; Sónia Silva
Journal:  Int J Mol Sci       Date:  2022-05-18       Impact factor: 6.208

Review 4.  Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.

Authors:  Uddalak Bharadwaj; Moses M Kasembeli; Prema Robinson; David J Tweardy
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

5.  Inhibition of the mTORC1/NF-κB Axis Alters Amino Acid Metabolism in Human Hepatocytes.

Authors:  Meng Zhang; Yuting Fu; Yuhao Chen; Yuze Ma; Zhixin Guo; Yanfeng Wang; Huifang Hao; Quan Fu; Zhigang Wang
Journal:  Biomed Res Int       Date:  2021-01-18       Impact factor: 3.411

6.  Obesity and Roux-en-Y gastric bypass drive changes in miR-31 and miR-215 expression in the human rectal mucosa.

Authors:  Stella Panagio Breininger; Laura Sabater; Fiona Caroline Malcomson; Sorena Afshar; Jelena Mann; John Cummings Mathers
Journal:  Int J Obes (Lond)       Date:  2021-10-29       Impact factor: 5.095

7.  [SP13786 Inhibits the Migration and Invasion of Lung Adenocarcinoma Cell A549 
by Supressing Stat3-EMT via CAFs Exosomes].

Authors:  Shushu Wang; Jiayu Cui; Kaijia Zhang; Jinhua Gu; Yuanhang Zheng; Baogang Zhang; Lihong Shi
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-05-24

8.  STAT3, a Hub Protein of Cellular Signaling Pathways, Is Triggered by β-Hexaclorocyclohexane.

Authors:  Elisabetta Rubini; Fabio Altieri; Silvia Chichiarelli; Flavia Giamogante; Stefania Carissimi; Giuliano Paglia; Alberto Macone; Margherita Eufemi
Journal:  Int J Mol Sci       Date:  2018-07-20       Impact factor: 5.923

Review 9.  Targeted inhibition of STAT3 as a potential treatment strategy for atherosclerosis.

Authors:  Qi Chen; Jianjun Lv; Wenwen Yang; Baoping Xu; Zheng Wang; Zihao Yu; Jiawei Wu; Yang Yang; Yuehu Han
Journal:  Theranostics       Date:  2019-08-14       Impact factor: 11.556

Review 10.  Curcumin and Weight Loss: Does It Work?

Authors:  Kamila Kasprzak-Drozd; Tomasz Oniszczuk; Marek Gancarz; Adrianna Kondracka; Robert Rusinek; Anna Oniszczuk
Journal:  Int J Mol Sci       Date:  2022-01-07       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.